Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001087363 | SCV000557043 | likely benign | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2023-12-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000456232 | SCV000714807 | likely benign | not provided | 2021-05-27 | criteria provided, single submitter | clinical testing | |
Center for Human Genetics, |
RCV000659505 | SCV000781324 | likely benign | Marfan syndrome | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001190174 | SCV001357605 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2018-11-21 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000602535 | SCV001737669 | likely benign | not specified | 2021-06-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001190174 | SCV002683154 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2022-03-23 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV000659505 | SCV004823099 | likely benign | Marfan syndrome | 2024-02-05 | criteria provided, single submitter | clinical testing |